Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:2-Hydroxyibuprofen)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003788 AN006227 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Meningitis Broad Institute of MIT and Harvard LC-MS
ST003788 AN006227 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Tuberculosis Broad Institute of MIT and Harvard LC-MS
ST003520 AN005780 Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas LC-MS
ST003356 AN005497 Noninvasive multiomic measurement of cell type repertoires in human urine Urine Human Urinary tract infection CZ Biohub LC-MS
ST003327 AN005451 Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics Blood Human Trauma University of Colorado Anschutz Medical Campus LC-MS
ST003066 AN005022 Heritability of RBC metabolites: baseline correlation of metabolites and markers of RBC health and stability Erythrocytes Human University of Iowa Other
ST003032 AN004971 Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens Urine Human National Center for Advancing Translational Sciences Other
ST002977 AN004889 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan LC-MS
ST002819 AN004591 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center Other
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine LC-MS
ST002471 AN004036 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004032 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health LC-MS
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health LC-MS
ST002027 AN003297 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) Blood Human University of California, Davis LC-MS
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center LC-MS
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST002003 AN003266 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001749 AN002849 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin-Madison LC-MS
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health LC-MS
ST001521 AN002536 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard LC-MS
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan LC-MS
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan LC-MS
ST001192 AN001986 A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research Feces Human Broad Institute of MIT and Harvard LC-MS
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000923 AN001515 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
  logo